Drug Shortage Report for OMNISCAN
Report ID | 137283 |
Drug Identification Number | 02172771 |
Brand name | OMNISCAN |
Common or Proper name | Gadodiamide injection USP |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GADODIAMIDE |
Strength(s) | 287MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 20 mL |
ATC code | V08CA |
ATC description | MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2021-04-09 |
Estimated end date | 2021-04-30 |
Actual end date | 2021-04-30 |
Shortage status | Resolved |
Updated date | 2021-05-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-05-01 | English | Compare |
v9 | 2021-04-30 | French | Compare |
v8 | 2021-04-30 | English | Compare |
v7 | 2021-04-23 | French | Compare |
v6 | 2021-04-23 | English | Compare |
v5 | 2021-04-13 | French | Compare |
v4 | 2021-04-13 | English | Compare |
v3 | 2021-04-10 | English | Compare |
v2 | 2021-04-09 | French | Compare |
v1 | 2021-04-09 | English | Compare |
Showing 1 to 10 of 10